Japanese Government Procurement

National University Corporation - Notice of Procurement (Goods & Services)A Polatuzumab Vedotin(Genetical Recombination, 30㎎/1vial) 398 vials,Ｂ　Sebelipase Alfa (Genetical Recombination, 20㎎ 10㎖／1vial) 89 vials,Ｃ　Pabinafusp Alfa（Genetical Recombination, 10㎎／1vial) 311 vials,Ｄ　Faricimab（Genetical Recombination, 120㎎ 0.24㎖／1vial) 345 vials,Ｅ　Cetuximab S...

This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.

Japanese

Publishing date Feb 01, 2024
Type of notice Notice of Procurement (Goods & Services)
Procurement entity National University Corporation - Tottori
Classification
0004 Medical & Pharmaceutical Products
Summay of notice ⑴ Official in charge of disbursement of the procuring entity : Hiromitsu Nakajima, President, Tottori University
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
A Polatuzumab Vedotin(Genetical Recombination, 30㎎/1vial) 398 vials
B Sebelipase Alfa (Genetical Recombination, 20㎎ 10㎖/1vial) 89 vials
C Pabinafusp Alfa(Genetical Recombination, 10㎎/1vial) 311 vials
D Faricimab(Genetical Recombination, 120㎎ 0.24㎖/1vial) 345 vials
E Cetuximab Sarotalocan Sodium(Genetical Recombination, 250㎎ 50㎖/1vial) 50 vials
F Nushinersen Sodium (12㎎/1vial) 2 vials
G Satralizumab (Genetical Recombination, 120㎎ 1㎖/1vial) 11 vials
H Polatuzumab Vedotin(Genetical Recombination, 140㎎/1vial) 11 vials
I Eculizumab (Genetical Recombination, 300㎎ 30㎖/1vail) 17 vials
J Onasemnogene abeparvovec Once
⑷ Delivery period : From 1 May, 2024 through 31 March, 2025
⑸ Delivery place : Department of Hospital Pharmacy, Tottori University Hospital
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A not come under Article 5 and 6 of the Regulation concerning the Contract for Tottori University Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause,
B have the Grade A, Grade B or Grade C qualification during fiscal 2024 in the Chugoku area in sales of product for participating in tenders by Single qualification for every ministry and agency, or have the Grade A, Grade B or Grade C qualification during fiscal 2024 in sales of product for participating in tenders by Tottori University,
C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,
D prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by President, Tottori University.
E not be currently under a suspension of business order as instructed by President, Tottori University.
⑺ Time limit of tender : 17 : 00 29 March, 2024
⑻ Contact point for the notice : Chiaki Sakamoto, Hospital Logistics Section, Accounting and Procurement Division, Yonago Administration Office, Tottori University, 36-1 Nishi-cho Yonago-shi 683-8504 Japan, TEL 0859-38-7068
⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.